No connection

Search Results

IZM vs SONM

IZM
ICZOOM Group Inc.
BEARISH
Price
$0.42
Market Cap
$5.1M
Sector
Technology
AI Confidence
85%
SONM
DNA X, Inc.
BEARISH
Price
$3.00
Market Cap
$4.5M
Sector
Technology
AI Confidence
95%

Valuation

P/E Ratio
IZM
4.25
SONM
--
Forward P/E
IZM
--
SONM
3.57
P/B Ratio
IZM
0.33
SONM
-4.35
P/S Ratio
IZM
0.03
SONM
--
EV/EBITDA
IZM
17.19
SONM
-3.97

Profitability

Gross Margin
IZM
3.31%
SONM
0.0%
Operating Margin
IZM
0.47%
SONM
0.0%
Profit Margin
IZM
0.64%
SONM
0.0%
ROE
IZM
7.76%
SONM
--
ROA
IZM
1.52%
SONM
-8.08%

Growth

Revenue Growth
IZM
7.2%
SONM
--
Earnings Growth
IZM
--
SONM
--

Financial Health

Debt/Equity
IZM
0.99
SONM
--
Current Ratio
IZM
1.58
SONM
0.6
Quick Ratio
IZM
1.15
SONM
0.03

Dividends

Dividend Yield
IZM
--
SONM
--
Payout Ratio
IZM
0.0%
SONM
0.0%

AI Verdict

IZM BEARISH

IZM presents a classic 'value trap' scenario; while the Piotroski F-Score of 6/9 indicates stable financial health and the stock trades significantly below its Graham Number ($1.7) and Intrinsic Value ($0.7), the price action is catastrophic. With a 75% decline over the last year and a technical trend score of 0/100, the market is pricing in a severe deterioration not yet fully reflected in the lagging P/E ratio. Razor-thin profit margins (0.64%) leave the company with virtually no margin for error in a volatile electronics distribution market.

Strengths
Extremely low P/E ratio of 4.25
Trading at a deep discount to book value (P/B 0.33)
Stable Piotroski F-Score (6/9)
Risks
Severe bearish momentum with an 81.8% drop in 6 months
Dangerously thin profit margins (0.64%)
Low revenue growth (7.2%) relative to technology sector peers
SONM BEARISH

The company exhibits extreme financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental health. With a Quick Ratio of 0.03 and a negative Price-to-Book ratio of -4.35, the firm is facing a severe liquidity crisis and possesses negative shareholders' equity. Catastrophic Q/Q revenue growth of -394.48% and a 5-year price decline of 99.7% suggest a business in terminal decline. The lack of an Altman Z-Score calculation is likely due to the absence of positive working capital or equity, further signaling insolvency risk.

Strengths
Recent reduction in quarterly EPS loss ($-9.36 vs $-25.38)
Low current price relative to 52-week high
Positive YoY EPS growth (though starting from a deep negative base)
Risks
Imminent insolvency risk due to Quick Ratio of 0.03
Negative shareholders' equity (Price/Book -4.35)
Catastrophic collapse in quarterly revenue (-394.48%)

Compare Another Pair

IZM vs SONM: Head-to-Head Comparison

This page compares ICZOOM Group Inc. (IZM) and DNA X, Inc. (SONM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile